Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-07 4:51 pm Unchanged | 2025-09-30 | 13G | GALMED PHARMACEUTICALS LTD SHS GLMD | CVI Investments, Inc. | 21,667 3.100% | 0 (Unchanged) | Filing History |
| 2025-08-14 2:01 pm Purchase | 2025-06-30 | 13G | GALMED PHARMACEUTICALS LTD SHS GLMD | CVI Investments, Inc. | 21,667 7.100% | 760 (+3.64%) | Filing History |
| 2025-02-18 4:15 pm Purchase | 2024-12-31 | 13G | GALMED PHARMACEUTICALS LTD SHS GLMD | Baharaff Allen | 5,516 2.600% | 2,209 (+66.80%) | Filing History |
| 2024-11-14 12:24 pm Purchase | 2024-09-30 | 13G | GALMED PHARMACEUTICALS LTD SHS GLMD | CVI Investments, Inc. | 20,907 9.900% | 16,586 (+383.85%) | Filing History |
| 2024-09-20 2:18 pm Unchanged | 2024-09-19 | 13G | MOMENTUS INC MNTS | Otsuka Masaya | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-09-20 2:17 pm Unchanged | 2024-09-18 | 13G | MOMENTUS INC MNTS | Otsuka Masaya | 0 9.900% | 0 (Unchanged) | Filing History |
| 2024-02-14 2:14 pm Purchase | 2023-12-31 | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | CVI Investments, Inc. | 4,321 9.900% | 2,159 (+99.86%) | Filing History |
| 2024-02-14 09:52 am Sale | 2023-12-31 | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | BIOTECHNOLOGY VALUE FUND L P | 0 0.000% | -1,208 (Position Closed) | Filing History |
| 2024-02-12 4:15 pm Purchase | 2023-12-31 | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | Baharaff Allen | 3,307 6.200% | 140 (+4.42%) | Filing History |
| 2023-07-21 10:12 am Purchase | 2023-07-14 | 13G | EOCENE LTD SHS PAR $ NIS 14.40 EOCN | CVI Investments, Inc. | 207,573 9.900% | 207,573 (New Position) | Filing History |
| 2023-02-14 12:03 pm Sale | 2022-12-31 | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | BIOTECHNOLOGY VALUE FUND L P | 1,208 6.900% | -42 (-3.36%) | Filing History |
| 2023-02-07 4:15 pm Purchase | 2022-12-31 | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | Baharaff Allen | 3,167 17.300% | 102 (+3.33%) | Filing History |
| 2022-02-14 08:14 am Sale | 2021-12-31 | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | Nantahala Capital Management, LLC | 207 1.200% | -1,131 (-84.53%) | Filing History |
| 2022-02-11 4:30 pm Purchase | 2021-12-31 | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | Baharaff Allen | 3,065 16.900% | 92 (+3.09%) | Filing History |
| 2022-01-27 4:32 pm Sale | 2021-12-31 | 13G | GALMED PHARMACEUTICALS LTD. SH GLMD | Ibex Investors LLC | 247 1.400% | -812 (-76.68%) | Filing History |